Asia-Pacific Obsessive-Compulsive Disorder (OCD) Drug Market - Industry Trends and Forecast to 2028
Asia-Pacific obsessive compulsive disorder (OCD) drugs market is projected to register a healthy CAGR of 10.2 % in the forecast period of 2021 to 2028. The new market report contains data for the historic year 2019, the base year of calculation is 2020, and the forecast period is 2021 to 2028.
Market Segmentation:
Asia-Pacific Obsessive Compulsive Disorder (OCD) Drugs Market, By Severity ( mild to moderate, moderate to severe), By Sub-Type (contamination obsessions with washing/ cleaning compulsion, harm obsessions with checking compulsions, obsessions without visible compulsions, symmetry obsessions with ordering, arranging, and, counting compulsions, hoarding, others), By Drugs (antidepressants, antipsychotics, NMDA blockers, others), By Route of Administration (oral, parenteral), By Population (pediatrics, adults), By End User (hospitals, speciality clinics, home healthcare, others), By Distribution Channel (hospital pharmacy, retail pharmacy, online pharmacy, others), By Country (Japan, China, Australia, India, South Korea, Singapore, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Rest of Asia-Pacific)- Industry Trends & Forecast to 2028
Some of the major factors contributing to the growth of Asia-Pacific obsessive compulsive disorder (OCD) drugs market are:
• Increasing prevalence of infectious diseases
• robust pipelines for development of newer treatment
• growth in awareness regarding the disorder
• growing demand for off-level drugs and therapies
Market Players:
The key market players for Asia-pacific obsessive compulsive disorder (OCD) drugs market are listed below:
• Sun pharmaceuticals industry Ltd.
• H.Lunderbeck A/S
• Teva pharmaceuticals USA. Inc (a subsidiary of Teva Pharmaceuticals Industries Ltd.)
• Eli Lilly and company
• Apotex Inc.
• Viatris Inc.
• GlaxoSmithKline Plc.
• Alvogen
• Pfizer Inc.
• Dr. Reddy’s Laboratories Ltd.
• Aurobindo Pharma USA (a subsidiary of Aurobindo Pharma)
• Others
Please note:The single user license is non-downloadable and non-printable. Global Site license allows these actions.
Please note: This publisher does offer titles that are created upon receipt of order. The report will take approximately 15-20 business days to prepare and deliver.
Short Description Asia-Pacific Obsessive Compulsive Disorder (OCD) Drugs Market, By Severity ( mild to moderate, moderate to severe), By Sub-Type (contamination obsessions with washing/ cleaning compulsion, harm obsessions with checking compulsions, obsessions without visible compulsions, symmetry obsessions with ordering, arranging, and, counting compulsions, hoarding, others), By Drugs (antidepressants, antipsychotics, NMDA blockers, others), By Route of Administration (oral, parenteral), By Population (pediatrics, adults), By End User (hospitals, speciality clinics, home healthcare, others), By Distribution Channel (hospital pharmacy, retail pharmacy, online pharmacy, others),By Country (Japan, China, Australia, India, South Korea, Singapore, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Rest of Asia-Pacific)- Industry Trends & Forecast to 2028 Market Definition: Obsessive compulsive disorder (OCD) is a disorder in which people have recurring, unwanted thoughts, ideas and sensations, that make them do same thing repeatedly. The symptoms associated with OCD are obsessions, compulsions, or both. These symptoms interfere with each aspect of life. In other words, it is referred to an anxiety disorder that is characterized by unreasonable and uncontrollable thoughts and fears leading an individual to perform repetitive behaviours. The disorder is known to compel a person to get stuck on a particular thought or fear. Increasing prevalence of infectious diseases among population across globe, robust pipelines for development of newer treatment, and growth in awareness regarding the disorder are driving the market growth. Moreover rise in quality concern, technological advancement for treatment of OCD, and strategic initiatives by key market players are expected to provide market with a lucrative growth opportunity in forecasted period. Market Segmentation: Obsessive compulsive disorder (OCD) drugs market is categorized into seven notable segments which are based on the basis of severity, sub-type, drugs, route of administration, population, end user, distribution channel • On the basis of severity, global obsessive compulsive disorder (OCD) drugs market is segmented into mild to moderate, moderate to severe. • On the basis of sub-type, global obsessive compulsive disorder (OCD) drugs market is segmented into contamination obsessions with washing/ cleaning compulsion, harm obsessions with checking compulsions, obsessions without visible compulsions, symmetry obsessions with ordering, arranging, and, counting compulsions, hoarding, others. • On the basis of route of administration, global obsessive compulsive disorder (OCD) drugs market is segmented into oral, parenteral • On the basis of population, global obsessive compulsive disorder (OCD) drugs market is segmented into paediatric, adult • On the basis of end user, global obsessive compulsive disorder (OCD) drugs market is segmented into hospitals, speciality clinics, home healthcare, others • On the basis of distribution channel, global obsessive compulsive disorder (OCD) drugs market is segmented into hospital pharmacy, retail pharmacy, online pharmacy, others Market Players: The key market players for Asia-pacific obsessive compulsive disorder (OCD) drugs market are listed below: • Sun pharmaceuticals industry Ltd. • H.Lunderbeck A/S • Teva pharmaceuticals USA. Inc (a subsidiary of Teva Pharmaceuticals Industries Ltd.) • Eli Lilly and company • Apotex Inc. • Viatris Inc. • GlaxoSmithKline Plc. • Alvogen • Pfizer Inc. • Dr. Reddy’s Laboratories Ltd. • Aurobindo Pharma USA (a subsidiary of Aurobindo Pharma) • Others
Learn how to effectively navigate the market research process to help guide your organization on the journey to success.
Download eBook